SEC Form 4 · accession 0001209191-15-066072
Viridian Therapeutics, Inc.\DE · VRDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tamara A Seymour
Officer — CFO, Secretary, Treasurer
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590750
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.57 | Aug 12, 2015 | A | 60,000 | A | — | Aug 12, 2025 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The option shall vest and become exercisable as to 15,000 shares on August 12, 2016 and the remainder shall vest in a series of 36 successive equal monthly installments thereafter beginning on September 12, 2016.